• 1
    Diekema D.J., Pfaller M.A., Schmitz F.J., Smayevsky J.J., Bell R., Jones N., Beach M. (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 15: S11432.
  • 2
    Centers for Disease Control and Prevention NNIS System. (2001) National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2001, issued August 2001. Am J Infect Control 28: 42948.
  • 3
    Bowrey D.J., Evans M.D., Clark G.W. (2007) Impact of methicillin-resistant Staphylococcus aureus infection on outcome after esophagectomy. World J Surg 31: 32631.
  • 4
    Scopetti F., Orefici G., Biondi F., Benini F. (1983) Staphylococcus aureus resistant to methicillin and gentamicin as a cause of outbreak of epidemic enteritis in a hospital. Boll Ist Sieroter Milan 62: 40611.
  • 5
    Yoshida D., Fukunari H., Hojo I., Kitago K., Ito M., Nihei Z., Inoue T., Mishima Y. (1992) Enterocolitis due to methicillin-resistant Staphylococcus aureus-report of two cases. Bull Tokyo Med Dent Univ 39: 314.
  • 6
    Christie C.D., Lynch-Ballard E., Andiman W.A. (1988) Staphylococcal enterocolitis revisited: cytotoxic properties of Staphylococcus aureus from a neonate with enterocolitis. Pediatr Infect Dis J 7: 79195.
  • 7
    Schiller B., Chiorazzi N., Farber B.F. (1998) Methicillin-resistant Staphylococcal enterocolitis. Am J Med 105: 16466.
  • 8
    Hitomi S., Kubota M., Mori N., Baba S., Yano H., Okuzumi K., Kimura S. (2000) Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 46: 12329.
  • 9
    Lally R.T., Lanz E., Schrock C.G. (2004) Rapid control of an outbreak of Staphylococcus aureus on a neonatal intensive care department using standard infection control practices and nasal mupirocin. Am J Infect Control 32: 447.
  • 10
    Nakano M., Miyazawa H., Kawano Y., Kawagishi M., Torii K., Hasegawa T., Iinuma Y., Ohta M. (2002) An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit. Microbiol Immunol 46: 27784.
  • 11
    Saiman L., Cronquist A., Wu F., Zhou J., Rubenstein D., Eisner W., Kreiswirth B.N., Della-Latta P. (2003) An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 24: 31721.
  • 12
    Shiojima T., Ohki Y., Nako Y., Morikawa A., Okubo T., Iyobe S. (2003) Immediate control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit. J Infect Chemother 9: 24347.
  • 13
    Lee Y.K., Nomoto K., Salminen S., Gorbach S.L. (1999) Probiotics. In: LeeY.K., NomotoK., SalminenS., GorbachS.L., eds. Handbook of Probiotics. New York : John Wiley & Sons, Inc, pp. 14.
  • 14
    Gibson G.R., Beatty E.R., Wang X., Cummings J.H. (1995) Selective stimulation of Bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108: 97582.
  • 15
    Colins M.D., Gibson G.R. (1999) Probiotics, prebiotics, and synbiotics approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69: S10527.
  • 16
    Asahara T., Nomoto K., Shimizu K., Watanuki M., Tanaka R. (2001) Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 91: 98596.
  • 17
    Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., Takeda Y. (2004) Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 72: 22407.
  • 18
    National Institutes of Health. (1985) Guide for the Care and Use of Laboratory Animals. National Institutes of Health publication No. 85-23. National Institutes of Health , Bethesda , MD .
  • 19
    Johnson W.M., Tyler S.D., Ewan E.P., Ashton F.E., Pollard D.R., Rozee K.R. (1991) Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol 29: 42630.
  • 20
    Wada M., Lkhagvadorj E., Bian L., Wang C., Chiba Y., Nagata S., Shimizu T., Yamashiro Y., Asahara T., Nomoto K. (2009) Quantitative reverse transcription-PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus. J Appl Microbiol: in press.
  • 21
    HoldemanL.V., CatoE.P., MooreW.E.C., eds. (1977) Anaerobe Laboratory Manual, 4th edn. Blacksburg : Virginia Polytechnic Institute and State University.
  • 22
    Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. (1999) Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol 65: 450612.
  • 23
    Sonoike K., Mada M., Mutai M. (1986) Selective agar medium for counting viable cells of bifidobacteria in fermented milk. J Food Hyg Soc Japan 27: 23844.
  • 24
    Yuki N., Matsumoto K., Takayama H., Morotomi M., Tanaka R. (1999) Isolation and identification of Bifidobacterium from feces of experimental rats: species identification and preparation of improved selective medium. J Intest Microbiol 12: 97102.
  • 25
    Ishikawa F., Takayama H., Matsumoto K., Ito M., Chonan O., Deguchi Y., Kikuchi-Hayakawa H., Watanuki M. (1995) Effects of β1–4 Linled Galactooligosaccharides on human fecal microflora. Bifidus 9: 518.
  • 26
    Petts D.N. (1984) Colistin-oxolinic acid-blood agar. A new selective medium for streptococci. J Clin Microbiol 19: 47.
  • 27
    Voravuthikunchai S.P., Lee A. (1987) Cecectomy causes long-term reduction of colonization resistance in the mouse gastrointestinal tract. Infect Immun 55: 9959.
  • 28
    Sugawara G., Nagino M., Nishio H., Ebata T., Takagi K., Asahara T., Nomoto K., Nimura Y. (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 244: 70614.
  • 29
    Takahata M., Sugiura Y., Ameyama S., Yotsuji A., Mitsuyama J., Sumiyama Y., Kusachi S. (2004) Influence of various antimicrobial agents on the intestinal flora in an intestinal MRSA-carrying rat model. J Infect Chemother 10: 33842.
  • 30
    Kato-Matsunaga N., Okonogi K. (1996) Gastrointestinal colonization by methicillin-resistant Staphylococcus aureus in immunosuppressed mice. Infect Immun 64: 42315.
  • 31
    Ota R., Takahashi C., Shiraishi T., Tominaga M. (2003) Relationship between methicillin resistant Staphylococcus aureus from inpatients and parenteral antibiotics. Kansenshogaku Zasshi 77: 104957.
  • 32
    Nomoto K., Yokokura T., Yoshikai Y., Mitsuyama M., Nomoto K. (1991) Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil. Can J Microbiol 37: 2447.
  • 33
    Kanamori Y., Hashizume K., Kitano Y., Tanaka Y., Morotomi M., Yuki N., Tanaka R. (2003) Anaerobic dominant flora was reconstructed by synbiotics in an infant with MRSA enteritis. Pediatr Int 45: 35962.
  • 34
    Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., Davis J.P. (1981) A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1: 101721.
  • 35
    Kain K.C., Schulzer M., Chow A.W. (1993) Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 16: 1006.
  • 36
    Jarraud S., Cozon G., Vandenesch F., Bes M., Etienne J., Lina G. (1999) Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 37: 24469.
  • 37
    Takizawa Y., Shimizu T., Iwaya A., Hatakeyama K., Taneike I., Nakagawa S., Nyuzuki S., Gondaira F., Tsukada H. (2003) A multiple superantigenic toxin pattern of methicillin-resistant Staphylococcus aureus (MRSA) as a risk factor in the development of toxic shock syndrome (TSS). Acta Med Biol (Niigata) 51: 1417.
  • 38
    Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. (1998) Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 351: 16149.
  • 39
    Cui L., Kasegawa H., Murakami Y., Hanaki H., Hiramatsu K. (1999) Postoperative toxic shock syndrome caused by a highly virulent methicillin- resistant Staphylococcus aureus strain. Scand J Infect Dis 31: 2089.
  • 40
    Kodama T., Santo T., Yokoyama T., Takesue Y., Hiyama E., Imamura Y., Murakami Y., Tsumura H., Shinbara K., Tatsumoto N., Matsuura Y. (1997) Postoperative enteritis caused by methicillin-resistant Staphylococcus aureus. Surg Today 27: 81625.
  • 41
    Dinges M., Jessurun J., Schlievert P. (1998) Comparisons of mouse and rabbit models of toxic shock syndrome. In: ArbuthnottJ., FurmanB., eds. European Conference on Toxic Shock Syndrome. International Congress and Symposium Series 229. New York : Royal Society of Medicine Press Ltd, pp. 167168.
  • 42
    Dinges M., Orwin P.M., Mievert P. (2000) Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 13: 1634.
  • 43
    Chuang Y.Y., Huang Y.C., Lee C.Y., Lin T.Y., Lien R., Chou Y.H. (2004) Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes. Acta Paediatr 93: 78690.
  • 44
    Shimizu K., Nomoto K. (2000) Bactericidal activity of probiotic culture on food-borne pathogens in vitro. Annual Report of Yakult Central Institute for Microbiological Research 20: 110.
  • 45
    Brocklehurst T.F., Lund B.M. (1990) The influence of pH, temperature and organic acids on the initiation of growth of Yersinia enterocolitica. J Appl Bacteriol 69: 3907.
  • 46
    Eklund T. (1983) The antimicrobial effect of dissociated and undissociated sorbic acid at different pH levels. J Appl Bacteriol 54: 3839.
  • 47
    Ogawa M., Shimizu K., Nomoto K., Tanaka R., Hamabata T., Yamasaki S., Takeda T., Takeda Y. (2001) Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int J Food Microbiol 68: 135140.